This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News Articles

Drug discovery must change to urgently address global health needs

Pharmaceutical research and development (R & D) is one of the best examples of human ingenuity, attracting vast funding and deploying the most advanced technologies. Over the past century, it has enabled unprecedented advances for human health. Yet the pharmaceutical R & D system is struggling to keep up with society’s medical needs.  More and better […]

Oxford University to receive £14 million in ERC Funding

Oxford University has won £14 million in new European Research Council (ERC) funding. Created to support innovative, high-impact research across the academic disciplines, the ERC offer 5-year grants to outstanding scientists and top researchers working in academia across Europe. Since it was founded in 2007 the funding body has awarded close to €12 billion across […]

The Hill Pitch Event

Sociologist Alex Rushforth from the Nuffield Department of Primary Care Health Sciences, recently attended Oxford’s annual digital health pitching event, The Hill, for the first time. Here’s what he made of it.   For the full story on Nuffield Department of Primary Care Health Sciences website

Triple win for Oxford at the RCPsych Awards 2017

Congratulations are pouring in for Oxford Health NHS Foundation Trust and University of Oxford – praised as leaders in their field by the Royal College of Psychiatrists. The Trust and the University are partners in the newly established NIHR Oxford Health BRC. For the full story on Oxford Health Biomedical Research Centre website

Involvement Matters – December 2017

Patients, carers, professionals and the public working together in the Thames Valley and Milton Keynes. Edition 12 – 4th December 2017  

News Categories: Newsletters

Celsion announces TARDOX study combining ThermoDox and focused ultrasound to tackle cancers

Celsion Corporation has launched a clinical trial, supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), to study the effectiveness of combining cancer drug ThermoDox with focused ultrasound to treat a range of tumours, including liver cancer. For the full story on Oxford Biomedical Research Centre website